1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA GRM2 CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA RIMKLA CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA DTL CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA SF3A2 CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA ZDHHC7 CTRPv2 pan-cancer AAC -0.17 2e-06
mRNA DST CTRPv2 pan-cancer AAC -0.17 2e-06
mRNA C11orf24 CTRPv2 pan-cancer AAC -0.16 2e-06
mRNA EMX1 CTRPv2 pan-cancer AAC 0.15 2e-06
mRNA ATP6V0E2 CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA TGIF2-C20orf24 CTRPv2 pan-cancer AAC -0.16 2e-06
Download CSV